UnitedHealth Group Incorporated (NYSE:UNH) has received a consensus recommendation of “Buy” from the twenty-six brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $202.38.
A number of research firms have commented on UNH. Cantor Fitzgerald reiterated a “buy” rating and set a $205.00 target price on shares of UnitedHealth Group in a research report on Friday, July 7th. Sanford C. Bernstein restated an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 10th. Credit Suisse Group restated an “outperform” rating and issued a $200.00 price objective (up from $195.00) on shares of UnitedHealth Group in a research report on Thursday, July 13th. Citigroup Inc. upped their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $212.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 20th.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now directly owns 1,818,898 shares in the company, valued at $348,700,935.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the sale, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold 25,600 shares of company stock valued at $4,962,694 over the last 90 days. 0.89% of the stock is currently owned by insiders.
A number of large investors have recently made changes to their positions in UNH. Patriot Financial Group Insurance Agency LLC increased its stake in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after acquiring an additional 603 shares during the last quarter. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $110,000. Kings Point Capital Management grew its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. grew its stake in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares in the last quarter. Institutional investors own 86.21% of the company’s stock.
Shares of UnitedHealth Group (NYSE:UNH) traded up 0.0318% on Tuesday, reaching $198.2330. The company’s stock had a trading volume of 1,092,460 shares. The stock has a market capitalization of $191.66 billion, a P/E ratio of 23.8146 and a beta of 0.63. The company has a 50 day moving average of $194.00 and a 200 day moving average of $179.23. UnitedHealth Group has a 1-year low of $132.39 and a 1-year high of $200.44.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.96 earnings per share. Equities research analysts expect that UnitedHealth Group will post $9.87 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio is presently 35.13%.
ILLEGAL ACTIVITY WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://ledgergazette.com/2017/09/15/unitedhealth-group-incorporated-unh-receives-202-38-consensus-pt-from-analysts.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com’s FREE daily email newsletter.